CN102406747A - Chinese medicinal composition for treating infant upper respiratory tract infection - Google Patents

Chinese medicinal composition for treating infant upper respiratory tract infection Download PDF

Info

Publication number
CN102406747A
CN102406747A CN2011103717525A CN201110371752A CN102406747A CN 102406747 A CN102406747 A CN 102406747A CN 2011103717525 A CN2011103717525 A CN 2011103717525A CN 201110371752 A CN201110371752 A CN 201110371752A CN 102406747 A CN102406747 A CN 102406747A
Authority
CN
China
Prior art keywords
grams
radix
respiratory tract
tract infection
chinese medicinal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2011103717525A
Other languages
Chinese (zh)
Inventor
林荣波
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rongcheng traffic clinic
Original Assignee
Rongcheng traffic clinic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rongcheng traffic clinic filed Critical Rongcheng traffic clinic
Priority to CN2011103717525A priority Critical patent/CN102406747A/en
Publication of CN102406747A publication Critical patent/CN102406747A/en
Pending legal-status Critical Current

Links

Abstract

For overcoming the defects of the existing Western medicine preparation on the treatment of the infant upper respiratory tract infection, the invention provides a Chinese medicinal composition for the treating infant upper respiratory tract infection. The Chinese medicinal composition for the treating infant upper respiratory tract infection is characterized by being prepared by compositing the following Chinese medicinal herbs according to the weight proportion: 8 to 12 grams of divaricate saposhnikovia root, 8 to 12 grams of rhizoma atractylodis macrocephalae, 4 to 8 grams of liquorice root, 18 to 22 grams of astragalus, 4 to 8 grams of flos magnoliae, 4 to 8 grams of dahurian angelica root, 8 to 12 grams of kudzuvine root, 8 to 12 grams of white chrysanthemum, 10 to 15 grams of mint, 8 to 12 grams of forsythia, 8 to 12 grams of platycodon grandiflorus, 8 to 12 grams of adenophora stricta, 8 to 12 grams of houttuynia cordata and 8 to 12 grams of almond. The Chinese medicinal composition has good treatment effect, has no side effects on a body and is difficult to generate the drug resistance. The technical defects caused by the adoption of the Western medicine to carry out injection treatment can be completely solved.

Description

A kind of Chinese medicine composition of treating infant upper respiratory tract infection
 
Technical field
The invention belongs to technical field of Chinese medicines, specifically be meant a kind of Chinese medicine composition of treating infant upper respiratory tract infection.
Background technology
Infant upper respiratory tract infection is the modal disease of children's, mainly invades nose, nasopharynx and pharyngeal, and diagnosis nouns such as " nasopharyngitis " therefore commonly used, " pharyngitis " " tonsillitis " also can be referred to as upper respiratory tract infection, is called for short " going up sense ".Nasopharynx infects and often can develop complications, and relates to adjacent organs such as larynx, trachea, lung, oral cavity, nasal sinuses, middle ear, eye and lymphonodi cervicales etc.Sometimes the symptom of nasopharynx part protopathy takes a turn for the better or disappears, and its complication can delay or increase the weight of, so must do comprehensively to observe and analyze the early treatment to the clinical characters of upper respiratory tract infection and complication thereof.
At present, the child in case the flu cause upper respiratory tract infection after, the head of a family be with more the child to the clinic or hospital carry out fluid infusion; Mostly the drop medicine is the biocide preparation of some antibioticses; Often effect was remarkable when child's initial stage fell ill, if but adopt this mode to treat for a long time, child's torso can develop immunity to drugs; Low dose of injection does not reach therapeutic effect at all, so the escalated dose of having to is treated.In the past for a long time, therapeutic effect difference but also bring greatly injury for child's health not only.
Summary of the invention
The objective of the invention is to the deficiency of present Western medicine class preparation childhood upper respiratory tract infection one disease treatment, provide a kind of therapeutic effect good, have no side effect, be difficult for producing chemical sproof Chinese medicine composition.
The technical scheme that the present invention adopts is: a kind of Chinese medicine composition of treating infant upper respiratory tract infection is characterized in that: this Chinese medicine composition is to adopt following materials of weight proportions drug regimen to form: windproof 8-12, Rhizoma Atractylodis Macrocephalae 8-12, Radix Glycyrrhizae 4-8, Radix Astragali 18-22, Flos Magnoliae 4-8, Radix Angelicae Dahuricae 4-8, Radix Puerariae 8-12, Flos Chrysanthemi 8-12, Herba Menthae 10-15, Fructus Forsythiae 8-12, Radix Platycodonis 8-12, Radix Adenophorae (Radix Glehniae) 8-12, Herba Houttuyniae 8-12, Semen Armeniacae Amarum 8-12.
The instructions of taking of above-mentioned Chinese medicine composition is to get above-mentioned Chinese medicine composition medicine juice according to the method for the fried Chinese medicine of tradition, every pair 100-200ml that takes concoction, and take for twice every day sooner or later.
The traditional Chinese medical science thinks and be prone to give birth to interior-heat, and child's respiratory system resistance is very weak, a flu so slightly, will in the foreign minister hold under the arm, cause upper respiratory tract infection.In the Chinese medicine composition provided by the present invention, windproof expelling pathogenic wind from the body surface, removing dampness to relieve pain, relieving convulsion are jerked surely; Rhizoma Atractylodis Macrocephalae invigorating the spleen and benefiting QI, dampness diuretic; Radix Glycyrrhizae heat-clearing and toxic substances removing, expelling phlegm for arresting cough; Radix Astragali benefiting QI for strengthening the superficies, arresting sweating take off admittedly; Flos Magnoliae dispels the wind cold, clearing the nasal passage; Radix Angelicae Dahuricae expelling wind and cold, understand things pain-stopping; Radix Puerariae is quenched one's thirst, plays cloudy gas, is separated all poison; Flos Chrysanthemi loose wind, heat-clearing and toxic substances removing; Menthol powder as one wind heat, clearing throat, dispersing the stagnated live-QI to relieve the stagnation of QI; Fructus Forsythiae heat-clearing and toxic substances removing, mass dissipating and swelling eliminating; Radix Platycodonis eliminating phlegm and stopping cough, lung qi dispersing, evacuation of pus; Radix Adenophorae (Radix Glehniae) clearing away heat and nourishing YIN, nourishing the lung to arrest cough; The Herba Houttuyniae heat-clearing and toxic substances removing; The Semen Armeniacae Amarum expelling phlegm for arresting cough, relieving asthma.All medicines in the above-mentioned Chinese medicine composition are played altogether, and upper respiratory tract infection one disease of treating the child is had tangible curative effect.This traditional Chinese medicine composition for treating is effective, and health is had no side effect, and is difficult for developing immunity to drugs, and can thoroughly solve extensively to adopt the existing technological deficiency of Western medicine injection for curing at present.
The specific embodiment
Below in conjunction with embodiment the present invention is further specified.
Embodiment 1
A kind of Chinese medicine composition of treating infant upper respiratory tract infection is characterized in that: this Chinese medicine composition is to adopt following materials of weight proportions drug regimen to form: windproof 10g, Rhizoma Atractylodis Macrocephalae 10g, Radix Glycyrrhizae 6g, Radix Astragali 20g, Flos Magnoliae 6g, Radix Angelicae Dahuricae 6g, Radix Puerariae 10g, Flos Chrysanthemi 10g, Herba Menthae 12g, Fructus Forsythiae 10g, Radix Platycodonis 10g, Radix Adenophorae (Radix Glehniae) 10g, Herba Houttuyniae 10g, Semen Armeniacae Amarum 10g.
Embodiment 2
A kind of Chinese medicine composition of treating infant upper respiratory tract infection is characterized in that: this Chinese medicine composition is to adopt following materials of weight proportions drug regimen to form: windproof 8g, Rhizoma Atractylodis Macrocephalae 12g, Radix Glycyrrhizae 4g, Radix Astragali 22g, Flos Magnoliae 4g, Radix Angelicae Dahuricae 8g, Radix Puerariae 8g, Flos Chrysanthemi 12g, Herba Menthae 10g, Fructus Forsythiae 12g, Radix Platycodonis 8g, Radix Adenophorae (Radix Glehniae) 12g, Herba Houttuyniae 8g, Semen Armeniacae Amarum 12g.
Embodiment 3
A kind of Chinese medicine composition of treating infant upper respiratory tract infection is characterized in that: this Chinese medicine composition is to adopt following materials of weight proportions drug regimen to form: windproof 12g, Rhizoma Atractylodis Macrocephalae 8g, Radix Glycyrrhizae 8g, Radix Astragali 18g, Flos Magnoliae 8g, Radix Angelicae Dahuricae 4g, Radix Puerariae 12g, Flos Chrysanthemi 8g, Herba Menthae 15g, Fructus Forsythiae 8g, Radix Platycodonis 12g, Radix Adenophorae (Radix Glehniae) 8g, Herba Houttuyniae 12g, Semen Armeniacae Amarum 8g.
A kind of Chinese medicine composition of treating infant upper respiratory tract infection, clinical efficacy is following:
One, general data: this Chinese medicine composition is applied to clinical observation case 25 examples, wherein male 12 examples, women 13 examples, 2~12 years old age.
Two, usage and dosage: during clinical practice, the component in the compositions, consumption are taken the circumstances into consideration increase and decrease according to patient's body weight, age and symptom.One day one pair, the about 100-200ml of twice extracting juice of decocting divides early, takes for late twice.
Three, criterion of therapeutical effect:
(1) recovery from illness: sings and symptoms disappears or basic the disappearance;
(2) produce effects: sings and symptoms is most of to take a turn for the better;
(3) invalid; Sings and symptoms does not all have obvious improvement, symptom such as preceding.
Four, therapeutic effect: in this clinical observation case, took medicine 3-7 days 20 examples of fully recovering, produce effects 3 examples, invalid 2 examples.
Five, model case:
Case 1:
The man, 11 years old, continuous three days sneeze, cough, pharyngalgia; Photophobia is shed tears, and eye is itched, generated heat, 38.5 ℃ of body temperature; Inspection finds that pharyngeal cavity and binding film are obviously congested, and the routine blood test numeration of leukocyte reduces, and percentage of lymphocyte increases; Taken the standing coldrex inefficacy of family, have a fever the 4th day night suddenly, takes temperature 39.5 ℃.
When adopting the measure of control body temperature, take above-mentioned Chinese medicine composition, took two days, transference cure recovers normal.
Case 2
Girl, 8 years old, the pharyngalgia degree was heavier, with heating, 39 ℃ of body temperature, inspection finds that the pharyngeal congestion soft palate is arranged, palate hangs down, there are canescence herpes and table ulcer in pharynx and tonsil surface, on every side around blush.
Take Chinese medicine composition provided by the invention after 1 week, each item transference cure, physical recovery is normal.

Claims (1)

1. Chinese medicine composition of treating infant upper respiratory tract infection is characterized in that: this Chinese medicine composition is to adopt following materials of weight proportions drug regimen to form: windproof 8-12, Rhizoma Atractylodis Macrocephalae 8-12, Radix Glycyrrhizae 4-8, Radix Astragali 18-22, Flos Magnoliae 4-8, Radix Angelicae Dahuricae 4-8, Radix Puerariae 8-12, Flos Chrysanthemi 8-12, Herba Menthae 10-15, Fructus Forsythiae 8-12, Radix Platycodonis 8-12, Radix Adenophorae (Radix Glehniae) 8-12, Herba Houttuyniae 8-12, Semen Armeniacae Amarum 8-12.
CN2011103717525A 2011-11-22 2011-11-22 Chinese medicinal composition for treating infant upper respiratory tract infection Pending CN102406747A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2011103717525A CN102406747A (en) 2011-11-22 2011-11-22 Chinese medicinal composition for treating infant upper respiratory tract infection

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2011103717525A CN102406747A (en) 2011-11-22 2011-11-22 Chinese medicinal composition for treating infant upper respiratory tract infection

Publications (1)

Publication Number Publication Date
CN102406747A true CN102406747A (en) 2012-04-11

Family

ID=45909284

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2011103717525A Pending CN102406747A (en) 2011-11-22 2011-11-22 Chinese medicinal composition for treating infant upper respiratory tract infection

Country Status (1)

Country Link
CN (1) CN102406747A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103239532A (en) * 2013-04-24 2013-08-14 王永红 Medicament for treating chronic pharyngitis and preparation method thereof
CN106798847A (en) * 2017-02-13 2017-06-06 四川双鑫生物科技有限公司 It is a kind of to treat decoction medicine of upper respiratory tract infection of children and preparation method thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101167996A (en) * 2007-09-20 2008-04-30 吴月 Traditional Chinese medicine for treating nasosinusitis
CN101972338A (en) * 2010-10-14 2011-02-16 尚德信 Chinese medicinal preparation for treating infantile upper respiratory tract infection and preparation method thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101167996A (en) * 2007-09-20 2008-04-30 吴月 Traditional Chinese medicine for treating nasosinusitis
CN101972338A (en) * 2010-10-14 2011-02-16 尚德信 Chinese medicinal preparation for treating infantile upper respiratory tract infection and preparation method thereof

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
> 19830228 马新云 浅谈小儿上感辨证施治及临床用药体会 14-17 1 , 第2期 *
> 19950930 熊磊 杨振邦治疗小儿上感用药经验浅谈 11-13 1 第18卷, 第3期 *
> 20080630 张玉英 柴葛解肌汤加减治疗小儿急性上感发热疗效观察 39-40 1 第25卷, 第3期 *
张玉英: "柴葛解肌汤加减治疗小儿急性上感发热疗效观察", <<甘肃中医学院学报>> *
熊磊: "杨振邦治疗小儿上感用药经验浅谈", <<云南中医学院学报>> *
马新云: "浅谈小儿上感辨证施治及临床用药体会", <<河北中医>> *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103239532A (en) * 2013-04-24 2013-08-14 王永红 Medicament for treating chronic pharyngitis and preparation method thereof
CN106798847A (en) * 2017-02-13 2017-06-06 四川双鑫生物科技有限公司 It is a kind of to treat decoction medicine of upper respiratory tract infection of children and preparation method thereof

Similar Documents

Publication Publication Date Title
CN101816757B (en) Chinese medicinal composition for treating antiaditis and preparation method thereof
CN103463609B (en) The preparation method of the Chinese herbal oral decoction Chinese patent drug of the treatment infection of the upper respiratory tract
CN102631610B (en) Chinese herb for treating pediatric chronic cough
CN103977314A (en) Medicinal composition for treating respiratory diseases as well as preparation method and application of medicinal composition
CN103330826A (en) Traditional Chinese medicine composition for treating deficiency of lung yin
CN104940485A (en) Traditional Chinese medicine composition for treating infantile asthma and preparation method thereof
CN102688444B (en) Traditional Chinese medicine for treating upper respiratory tract infection and preparation method thereof
CN102670870B (en) Chinese herb preparation for curing acute suppurative tonsillitis of children
CN103505652A (en) Traditional Chinese medicine composition used for treating children cough with lung heat
CN103272138A (en) Traditional Chinese medicine for treating rubella
CN102908565A (en) Chinese herbal medicine decoction for curing bronchial asthma and preparation method of Chinese herbal medicine decoction
CN103341063B (en) Chinese medicine composition for treating wind-heat cough
CN103479932B (en) One treats bronchitic Chinese medicine composition and preparation method thereof
CN102406747A (en) Chinese medicinal composition for treating infant upper respiratory tract infection
CN102716400B (en) Lung-heat clearing and cough relieving soup for babies
CN103585360A (en) Traditional Chinese medicinal preparation for treating upper respiratory tract infection
CN103386081B (en) Traditional Chinese medicine preparation for curing respiratory tract infection in clinical nursing
CN106237056A (en) A kind of Chinese medicine decoction treating chronic bronchitis
CN105250968A (en) Traditional Chinese medicine preparation for treating asthma
CN103417809B (en) TCM preparation for treatment of thrush in infants and children
CN102657709A (en) A traditional Chinese medicine for treating rhinitis
CN103989919A (en) Traditional Chinese medicine composition for relieving cough and resolving phlegm
CN103463376A (en) Chinese herbal preparation for treating children chronic cough
CN103251925B (en) Traditional Chinese medicine pill for treating diphtheria
CN103223075B (en) Traditional Chinese medicinal capsule for treating diphtheria

Legal Events

Date Code Title Description
PB01 Publication
C06 Publication
SE01 Entry into force of request for substantive examination
C10 Entry into substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20120411

C02 Deemed withdrawal of patent application after publication (patent law 2001)